We are live on ! Find out more
EVM

Evelyn V. Moreno Portfolio holdings

AUM $212M
1-Year Est. Return 31.13%
This Fund
S&P 500
This Quarter Est. Return
-15.95%
1 Year Est. Return
+31.13%
3 Year Est. Return
+39.44%
5 Year Est. Return
+122.36%
10 Year Est. Return
+222.57%
AUM
$429M
AUM Growth
-$65.3M
Cap. Flow
+$22.7M
Cap. Flow %
5.3%
Top 10 Hldgs %
35.52%
Holding
165
New
56
Increased
37
Reduced
36
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.07M
2
AMZN icon
Amazon
AMZN
+$2.59M
3
NKE icon
Nike
NKE
+$1.39M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26M
5
COST icon
Costco
COST
+$1.07M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.98M
2
CVS icon
CVS Health
CVS
+$2.7M
3
PYPL icon
PayPal
PYPL
+$2.26M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.77M
5
AAPL icon
Apple
AAPL
+$1.2M

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 13.91%
3 Financials 13.27%
4 Communication Services 8.73%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
76
ExxonMobil
XOM
$644B
$587K 0.14%
+6,860
New +$619K
COP icon
77
ConocoPhillips
COP
$147B
$575K 0.13%
+6,400
New +$659K
DVN icon
78
Devon Energy
DVN
$52.1B
$571K 0.13%
+10,355
New +$676K
UNP icon
79
Union Pacific
UNP
$174B
$559K 0.13%
+2,621
New +$596K
AMAT icon
80
Applied Materials
AMAT
$403B
$542K 0.13%
5,961
+4,000
+204% +$439K
EG icon
81
Everest Group
EG
$14.5B
$538K 0.13%
+1,920
New +$543K
LRCX icon
82
Lam Research
LRCX
$367B
$537K 0.13%
+12,590
New +$599K
VZ icon
83
Verizon
VZ
$195B
$537K 0.13%
+10,591
New +$536K
APD icon
84
Air Products & Chemicals
APD
$65.7B
$535K 0.12%
2,225
+85
+4% +$20.7K
NEM icon
85
Newmont
NEM
$98.7B
$534K 0.12%
+8,949
New +$633K
CVX icon
86
Chevron
CVX
$392B
$528K 0.12%
+3,650
New +$603K
AMGN icon
87
Amgen
AMGN
$208B
$513K 0.12%
+2,110
New +$517K
NVO
88
Novo Nordisk
NVO
$208B
$500K 0.12%
8,978
+500
+6% +$27.7K
GILD icon
89
Gilead Sciences
GILD
$162B
$495K 0.12%
+8,004
New +$496K
BKR icon
90
Baker Hughes
BKR
$60B
$470K 0.11%
+16,274
New +$550K
COF icon
91
Capital One
COF
$128B
$457K 0.11%
+4,386
New +$536K
VEA icon
92
Vanguard FTSE Developed Markets ETF
VEA
$229B
$449K 0.1%
+11,000
New +$489K
PKG icon
93
Packaging Corp of America
PKG
$21.9B
$440K 0.1%
+3,200
New +$494K
A icon
94
Agilent Technologies
A
$39.1B
$426K 0.1%
+3,586
New +$441K
EMR icon
95
Emerson Electric
EMR
$83.9B
$424K 0.1%
+5,335
New +$470K
GS icon
96
Goldman Sachs
GS
$300B
$422K 0.1%
+1,420
New +$442K
WMT icon
97
Walmart Inc
WMT
$885B
$419K 0.1%
+10,350
New +$477K
IVV icon
98
iShares Core S&P 500 ETF
IVV
$878B
$408K 0.1%
+1,075
New +$442K
ASML icon
99
ASML
ASML
$626B
$406K 0.09%
854
WTW icon
100
Willis Towers Watson
WTW
$31.2B
$405K 0.09%
+2,050
New +$439K

Similar funds

Evelyn V. Moreno's Q2 2022 Portfolio in Review

As of Q2 2022, Evelyn V. Moreno held 165 positions worth $429M, down 13% from $494M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Evelyn V. Moreno deployed $22.7M of net new capital in Q2 2022, opening 56 new positions and adding to 37 existing holdings. Its largest new stake was Bunge Global: 7,000 shares worth $635K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $2.98M trimmed.

  • Evelyn V. Moreno's largest Q2 2022 buy was Bunge Global: 7,000 shares worth $635K.
  • Evelyn V. Moreno added most to Bristol-Myers Squibb in Q2 2022, an estimated $5.07M increase.
  • Evelyn V. Moreno's biggest Q2 2022 reduction was Novartis, cutting an estimated $2.98M.
  • Evelyn V. Moreno fully exited SVB Financial Group in Q2 2022, selling an estimated $272K.
  • Evelyn V. Moreno's ten largest holdings make up 36% of its $429M portfolio in Q2 2022.
  • Evelyn V. Moreno opened 56 new positions and closed 7 in Q2 2022.
  • Evelyn V. Moreno's portfolio value fell 13% quarter-over-quarter to $429M.

Based on Evelyn V. Moreno's 13F filing for Q2 2022, filed 11 Aug 2022.